Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
1.270
-0.020 (-1.55%)
At close: Jun 12, 2025, 4:00 PM
1.300
+0.030 (2.36%)
After-hours: Jun 12, 2025, 6:05 PM EDT

Gossamer Bio Statistics

Total Valuation

Gossamer Bio has a market cap or net worth of $288.67 million. The enterprise value is $238.07 million.

Market Cap 288.67M
Enterprise Value 238.07M

Important Dates

The last earnings date was Thursday, May 15, 2025, after market close.

Earnings Date May 15, 2025
Ex-Dividend Date n/a

Share Statistics

Gossamer Bio has 227.30 million shares outstanding. The number of shares has increased by 22.21% in one year.

Current Share Class 227.30M
Shares Outstanding 227.30M
Shares Change (YoY) +22.21%
Shares Change (QoQ) +0.09%
Owned by Insiders (%) 3.13%
Owned by Institutions (%) 58.88%
Float 183.75M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.35
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio 32.28
P/OCF Ratio 32.19
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.91
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 26.21

Financial Position

The company has a current ratio of 5.71

Current Ratio 5.71
Quick Ratio 5.49
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF 22.32
Interest Coverage -4.92

Financial Efficiency

Return on equity (ROE) is -500.57% and return on invested capital (ROIC) is -15.84%.

Return on Equity (ROE) -500.57%
Return on Assets (ROA) -12.68%
Return on Invested Capital (ROIC) -15.84%
Return on Capital Employed (ROCE) -23.57%
Revenue Per Employee $859,241
Profits Per Employee -$353,366
Employee Count 145
Asset Turnover 0.46
Inventory Turnover n/a

Taxes

In the past 12 months, Gossamer Bio has paid $893,000 in taxes.

Income Tax 893,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +148.82% in the last 52 weeks. The beta is 1.85, so Gossamer Bio's price volatility has been higher than the market average.

Beta (5Y) 1.85
52-Week Price Change +148.82%
50-Day Moving Average 1.05
200-Day Moving Average 1.00
Relative Strength Index (RSI) 58.64
Average Volume (20 Days) 1,520,466

Short Selling Information

The latest short interest is 11.08 million, so 4.88% of the outstanding shares have been sold short.

Short Interest 11.08M
Short Previous Month 10.54M
Short % of Shares Out 4.88%
Short % of Float 6.03%
Short Ratio (days to cover) 6.71

Income Statement

In the last 12 months, Gossamer Bio had revenue of $124.59 million and -$51.24 million in losses. Loss per share was -$0.23.

Revenue 124.59M
Gross Profit 124.59M
Operating Income -54.77M
Pretax Income -172.58M
Net Income -51.24M
EBITDA -54.19M
EBIT -54.77M
Loss Per Share -$0.23
Full Income Statement

Balance Sheet

The company has $257.93 million in cash and $202.79 million in debt, giving a net cash position of $55.15 million or $0.24 per share.

Cash & Cash Equivalents 257.93M
Total Debt 202.79M
Net Cash 55.15M
Net Cash Per Share $0.24
Equity (Book Value) -6.25M
Book Value Per Share -0.03
Working Capital 227.25M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $9.11 million and capital expenditures -$26,000, giving a free cash flow of $9.08 million.

Operating Cash Flow 9.11M
Capital Expenditures -26,000
Free Cash Flow 9.08M
FCF Per Share $0.04
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -43.96% and -41.13%.

Gross Margin 100.00%
Operating Margin -43.96%
Pretax Margin -40.41%
Profit Margin -41.13%
EBITDA Margin -43.49%
EBIT Margin -43.96%
FCF Margin 7.29%

Dividends & Yields

Gossamer Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -22.21%
Shareholder Yield -22.21%
Earnings Yield -17.47%
FCF Yield 3.10%

Analyst Forecast

The average price target for Gossamer Bio is $7.75, which is 510.24% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.75
Price Target Difference 510.24%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 25.76%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Gossamer Bio has an Altman Z-Score of -5.3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.3
Piotroski F-Score 2